Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Winky Lai
Institution:
Prince of Wales Hospital
Observed institution:
Prince of Wales Hospital
ORCID:
0009-0002-7227-2235
Observed ORCID:
0009-0002-7227-2235
OpenAlex ID:
A5113320770
Supplementary Figure S3 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Data from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Supplementary Figure S1 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Supplementary Figure S2 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Supplementary Figure S4 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Supplementary Table S3 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Supplementary Table S2 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Supplementary Table S1 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Supplementary Table S4 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
Supplementary Methods S1 from A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas
2026
·
Jia Li Low
, Wan Qin Chong
, et al.
·
Clinical Cancer Research
Abstract 7338: Evaluation of a novel target Claudin1 in preclinical models of nasopharyngeal carcinoma
2025
·
Kar Wei Chin
, Connie Wun Chun Hui
, et al.
·
Cancer Research
A phase 2 study of trifluridine/tipiracil (FTD/TPI) in recurrent/metastatic nasopharyngeal (r/m NPC) carcinomas with or without prior exposure to fluoropyrimidines.
2024
·
Jia Li Low
, Wan Qin Chong
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
13
Citation count:
H-index:
I10-index:
Year
Topic
Type